Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
PPLPHARMA •NSE
Piramal Pharma
₹212.532.29 (1.09%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Performance
Today’s low
209.37
Today’s high
216.93
52 week low
132.30
52 week high
218.50
Open price
210.25
Previous close
210.24
Live volume
18,10,180
Lower circuit
168.20
Upper circuit
252.28
Fundamentals
Market Cap
₹28,005Cr
ROE
-3.58%
P/E Ratio(TTM)
--
EPS(TTM)
-2.36
P/B Ratio
3.43
Dividend Yield
0.00%
Industry P/E
37.57
Book Value
61.34
Debt to Equity
0.70
Face Value
10
Financial performance
JUN '26
Revenue (Cr)
₹2,359
-15.67%
Profit (Cr)
-₹69.39
-685.84%
-40004001.6k3.6k
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +18% |
| 3Y CAGR | +8% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +18% |
| 3Y CAGR | -17% |
About
Piramal Pharma Limited is a global pharmaceutical company with a presence in over 100 countries. It operates through three main business segments: a) Piramal Pharma Solutions (PPS): An integrated Contract Development and Manufacturing Organization (CDMO). b) Piramal Critical Care (PCC): A complex hospital generics business focusing on inhalation anesthetics and injectables. c) India Consumer Healthcare (ICH): A retail business selling well-known over-the-counter (OTC) brands like Saridon, Lacto Calamine, and i-pill.;
Founded in
2020
NSE symbol
PPLPHARMA
Shareholding pattern
Mutual Funds Invested (4)
Similar stocks
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Neuland LaboratoriesNEULANDLAB | ₹23,115.00 +605.00 (2.69%) | 28,874.43 | 58.01 | 15.41 | ||
Onesource Specialty PharmaONESOURCE | ₹1,565.60 +26.40 (1.72%) | 17,656.19 | -- | 3.03 | ||
Cohance LifesciencesCOHANCE | ₹443.45 -0.90 (0.20%) | 17,005.11 | 290.52 | 4.35 | ||
Syngene InternationalSYNGENE | ₹401.10 -7.55 (1.85%) | 16,506.03 | 74.75 | 3.41 |
Livesquawk •
Piramal Pharma Ltd. executed NSE block trade of 1,454,194 shares.
Trade valued at Rs. 29.8 crores, priced at Rs. 205.01 per share.
Livesquawk •
Piramal Pharma restarts Ahmedabad unit operations post flood disruption.
Production resumes after flood-related interruption at Ahmedabad units.
Livesquawk •
Goldman Sachs maintains Buy on Piramal Pharma with a target price of ₹250.
Q1 revenue, EBITDA beat estimates, sharp margin expansion, FY27 guidance reaffirmed.
Livesquawk •
Piramal Pharma expects a normalized tax rate of 24-25% at scale.
Tax rate will remain elevated during the current fiscal year, per concall.
Livesquawk •
Piramal Pharma reaffirmed FY guidance for Complex Hospital Generics, including organic and Kenalog growth.
Q1 organic growth rate is unlikely to persist throughout the year, as per concall update.
Livesquawk •
Piramal Pharma reaffirmed full-year CDMO guidance, citing H2 revenue seasonality.
Q1 started strong with an above-average opening order book, per management.
2026
29
Jul
Quarterly Result
Release date
28
Apr
Quarterly & Annual Result
Release date
28
Jan
Quarterly Result
Release date
2025
5
Nov
Quarterly Result
Release date
28
Jul
Quarterly Result
Release date
16JulDividendEx date₹0.14per share
16
Jul
Dividend
Ex date
₹0.14
per share
For each share you hold, you will receive ₹0.14
Dividend amount₹0.14 per share
Dividend TypeFinal
Ex Date16 Jul ‘25
Record Date16 Jul ‘25
Announcement date14 May ‘25
14MayDividendAnnounced₹0.14per share
14
May
Dividend
Announced
₹0.14
per share
For each share you hold, you will receive ₹0.14
Dividend amount₹0.14 per share
Dividend TypeFinal
Ex Date16 Jul ‘25
Record Date16 Jul ‘25
Announcement date14 May ‘25
Events calendar
View upcoming events in other stocks